| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06970782 | Vebreltinib Plus PLB1004 Versus Platinum-based Doublet Chemotherapy in Patients With… | Non-Small-Cell Lung Cancer | Not Yet Recruiting |
| NCT06281964 | Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring… | Non-Small-Cell Lung Cancer | Enrolling by Invitation |
| Phase 2 | |||
| NCT06574347 | Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally… | Non-Small-Cell Lung Cancer | Recruiting |
| NCT07336732 | Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet… | Non-Small-Cell Lung Cancer | Recruiting |
| NCT06015503 | A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation… | NSCLC (Non-small Cell Lung Cancer) | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06343064 | Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET… | Non-Small-Cell Lung Cancer | Recruiting |
| NCT07538804 | A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell… | Non-Small Cell Lung Cancer | Recruiting |
| Phase 1 | |||
| NCT06046495 | A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer | Recruiting |
| NCT06716138 | A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid… | Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration | Recruiting |
| NCT06307795 | A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic… | Locally Advanced or Metastatic Solid Tumors | Recruiting |
| NCT06328439 | A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Solid Tumors | Active, Not Recruiting |